Accrued Liabilities, Current of Innovation1 Biotech Inc. from 31 Aug 2018 to 29 Feb 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Innovation1 Biotech Inc. quarterly Accrued Liabilities, Current in USD history and change rate from 31 Aug 2018 to 29 Feb 2024.
  • Innovation1 Biotech Inc. Accrued Liabilities, Current for the quarter ending 29 Feb 2024 was $179,170, a 68% decline year-over-year.
Source SEC data
View on sec.gov
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $179,170 -$379,129 -68% 29 Feb 2024 10-Q 06 May 2025 2024 Q2
Q4 2023 $162,219 +$63,349 +64% 30 Nov 2023 10-Q 27 Jan 2025 2023 Q1
Q3 2023 $1,072,108 +$1,032,550 +2610% 31 Aug 2023 10-Q 06 May 2025 2024 Q2
Q2 2023 $539,680 +$504,125 +1418% 31 May 2023 10-Q 13 Sep 2023 2023 Q3
Q1 2023 $558,299 +$545,785 +4361% 28 Feb 2023 10-Q 30 May 2023 2023 Q2
Q4 2022 $98,870 -$4,428 -4.3% 30 Nov 2022 10-Q 17 Jan 2023 2023 Q1
Q3 2022 $39,558 +$37,502 +1824% 31 Aug 2022 10-K 17 Jan 2024 2023 FY
Q2 2022 $35,555 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 $12,514 28 Feb 2022 10-Q 15 Apr 2022 2022 Q2
Q4 2021 $103,298 30 Nov 2021 10-Q/A 01 Feb 2022 2022 Q1
Q3 2021 $2,056 31 Aug 2021 10-K 15 Dec 2022 2022 FY
Q4 2019 $2,079 +$1,480 +247% 30 Nov 2019 10-Q 21 Jan 2020 2020 Q1
Q3 2019 $1,014 +$539 +113% 31 Aug 2019 10-Q 21 Jan 2020 2020 Q1
Q2 2019 $845 31 May 2019 10-Q 18 Jul 2019 2019 Q3
Q1 2019 $599 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 $599 30 Nov 2018 10-Q 18 Jan 2019 2019 Q1
Q3 2018 $475 31 Aug 2018 10-K 17 Dec 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.